{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:10:05Z","timestamp":1788516605001,"version":"build-2803163510"},"reference-count":58,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>As the characteristics of preterm infants with retinopathy of prematurity (ROP) vary, depending on the quality of neonatal care they received, universal screening criteria for ROP are not possible. The purpose of this study was to compare ROP guidelines for those planning to develop guidelines, particularly in resource-poor settings.<\/jats:p>\n                  <jats:p>A systematic review was undertaken of PubMed, Embase and guidelines registers to identify national or international policy statements or guidelines in English, issued or operational in 2010\u20132021. Bibliographies of two publications were also reviewed. The searches identified 633, 1081 and 317 records, respectively, and 157 records were retrieved from other sources. 23 publications were included in the analysis.<\/jats:p>\n                  <jats:p>Most included documents defined cut-offs for screening as &lt;32 weeks gestational age (GA) or \u22641500g birth weight (BW). The highest values were in the Philippines (&lt;35 weeks GA; &lt;2000g) and India (\u226434 weeks GA; &lt;2000g). The lowest were in high-income countries, i.e. the United States of America (\u226432 weeks for GA) and New Zealand (&lt;1250g for BW). Most guidelines included additional risk factors to consider. The most frequent indication for when screening should start was a combination of GA and chronological age. All but one document defined when screening could stop. There was general consensus on the indications, timing and methods of treatment. Indications for anti-VEGF therapy varied between countries.<\/jats:p>\n                  <jats:p>Guidelines were identified for a limited number of countries with none from low-income settings. Variation in the indications for screening reflects the varying exposure to risk factors in different settings.<\/jats:p>","DOI":"10.1177\/11206721221126286","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:52:35Z","timestamp":1663548755000},"page":"667-681","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Systematic review of the guidelines for retinopathy of prematurity"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4912-4413","authenticated-orcid":false,"given":"Micha\u0142","family":"Ko\u015bci\u00f3\u0142ek","sequence":"first","affiliation":[{"name":"University Clinical Center of the Medical University of Warsaw Central Clinical Hospital, Warsaw, Poland"},{"name":"Warsaw Genomics, Warsaw, Poland"},{"name":"Students\u2019 Scientific Group \u201cLens\u201d, Department of Ophthalmology, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9901-2391","authenticated-orcid":false,"given":"Weronika","family":"Kisielewska","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Group \u201cLens\u201d, Department of Ophthalmology, Medical University of Warsaw, Warsaw, Poland"},{"name":"Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0669-5969","authenticated-orcid":false,"given":"Marlena","family":"\u0106wiklik-Wierzbowska","sequence":"additional","affiliation":[{"name":"Military Institute of Medicine, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0967-5218","authenticated-orcid":false,"given":"Piotr","family":"Wierzbowski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Endocrinology, University Clinical Center of the Medical University of Warsaw Central Clinical Hospital, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,9,18]]},"reference":[{"key":"bibr1-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60178-6"},{"key":"bibr2-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.205"},{"key":"bibr3-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000645"},{"key":"bibr4-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-310129"},{"key":"bibr5-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-018-1355-8"},{"key":"bibr6-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-014-1648-z"},{"key":"bibr7-11206721221126286","first-page":"167","volume":"58","author":"Melesse MA","year":"2020","journal-title":"Ethiop Med J"},{"key":"bibr8-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.12.1684"},{"key":"bibr9-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1180"},{"key":"bibr10-11206721221126286","unstructured":"Royal College of Paediatrics and Child Health, Royal College of Ophthalmologists, British Association of Perinatal Medicine, et al. Guideline for the Screening and Treatment of Retinopathy of Prematurity, https:\/\/www.rcpch.ac.uk\/sites\/default\/files\/2018-03\/guideline_for_the_screening_and_treatment_of_retinopathy_of_prematurity_2008-05.pdf (2008, accessed 4 March 2021)."},{"key":"bibr11-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.5373"},{"key":"bibr12-11206721221126286","unstructured":"Trip Database. Retinopathy, https:\/\/www.tripdatabase.com\/Searchresult?category=%2816%20OR%2018%20OR%209%20OR%2010%20OR%204%29&comparison=&criteria=retinopathy&intervention=&outcome=&search_type=pico (2020, accessed 2 December 2021)."},{"key":"bibr13-11206721221126286","unstructured":"EBSCO Information Services. GIN international guideline library and registry of guidelines in development, https:\/\/guidelines.ebmportal.com\/guidelines-international-network?search=retinopathy&type=search (2020, accessed 1 December 2021)."},{"key":"bibr14-11206721221126286","unstructured":"Guideline Central. Retinopathy, https:\/\/www.guidelinecentral.com\/?s=retinopathy (2021, accessed 1 December 2021)."},{"key":"bibr15-11206721221126286","unstructured":"Guidelines in practice. Search results, https:\/\/www.guidelinesinpractice.co.uk\/searchresults?qkeyword=retinopathy (2021, accessed 5 December 2021)."},{"key":"bibr16-11206721221126286","unstructured":"Guidelines. Search results, https:\/\/www.guidelines.co.uk\/searchresults?qkeyword=retinopathy (2021, accessed 1 December 2021)."},{"key":"bibr17-11206721221126286","unstructured":"Geneva Foundation for Medical Education and Research. Obstetrics and gynecology guidelines, Retinopathy of prematurity, https:\/\/www.gfmer.ch\/Guidelines\/Neonatology\/Retinopathy_prematurity.htm (2021, accessed 7 December 2021)."},{"key":"bibr18-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310709"},{"key":"bibr19-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2019.05.007"},{"key":"bibr20-11206721221126286","unstructured":"Kremer L, van Dalen E. Cochrane Childhood Cancer Module 2, https:\/\/childhoodcancer.cochrane.org\/sites\/childhoodcancer.cochrane.org\/files\/public\/uploads\/cochrane_childhood_cancer_module.pdf (2018, accessed 4 November 2021)."},{"key":"bibr21-11206721221126286","unstructured":"Canadian Journal of Health Technologies. Strings attached: CADTH database search filters, https:\/\/www.cadth.ca\/strings-attached-cadths-database-search-filters (2021, accessed 4 November 2021)."},{"key":"bibr22-11206721221126286","volume-title":"WHO Handbook for guideline development","author":"World Health Organization","year":"2014","edition":"2"},{"key":"bibr23-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"bibr24-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"bibr25-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1177\/0973217920934397"},{"key":"bibr26-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3061"},{"key":"bibr27-11206721221126286","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.6305"},{"key":"bibr28-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2018.07.007"},{"key":"bibr29-11206721221126286","doi-asserted-by":"publisher","DOI":"10.5152\/TurkPediatriArs.2018.01815"},{"key":"bibr30-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/21.2.101"},{"key":"bibr31-11206721221126286","unstructured":"Ministry of Health & Family Welfare India. Guidelines for Universal Eye Screening in Newborns Including Retinopathy of Prematurity, http:\/\/www.nhm.gov.in\/images\/pdf\/programmes\/RBSK\/Resource_Documents\/Revised_ROP_Guidelines-Web_Optimized.pdf (2017, accessed 16 March 2021)."},{"key":"bibr32-11206721221126286","unstructured":"Pan American Health Organization. Clinical Practice Guidelines for the Management of Retinopathy of Prematurity. Summarized Version 2017, https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/51089\/PAHOFPL19001_eng.pdf (2019, accessed 4 March 2021)."},{"key":"bibr33-11206721221126286","unstructured":"Philippine Academy of Ophthalmology, Pao\u2013Retinopathy of Prematurity Working Group, Pao\u2013Philippine Society of Pediatric Ophthalmology and Strabismus, et al. Recommended Philippine Guidelines for Screening and Referral of Retinopathy of Prematurity (ROP), https:\/\/vrsp.org.ph\/wp-content\/uploads\/2018\/08\/2013-ROP-GUIDELINES-ver.112613.pdf (2013, accessed 4 March 2021)."},{"key":"bibr34-11206721221126286","unstructured":"College of Ophthalmologists of Sri Lanka and Perinatal Society of Sri Lanka. National Guidelines for Screening for Retinopathy of Prematurity, https:\/\/www.cosl.lk\/pdf\/rop-guide-lines.pdf (2019, accessed 17 March 2021)."},{"key":"bibr35-11206721221126286","unstructured":"Public Health Foundation of India, Indian Institute of Public Health Hyderabad, London School of Hygiene & Tropical Medicine, et al. Project Operational Guidelines. Prevention of Blindness from Retinopathy of Prematurity in Neonatal Care Units, https:\/\/phfi.org\/wp-content\/uploads\/2019\/05\/2018-ROP-operational-guidelines.pdf (2018, accessed 17 March 2021)."},{"key":"bibr36-11206721221126286","unstructured":"Ministry of Health Malaysia and Academy of Medicine Malaysia. Clinical Practice Guidelines. Retinopathy of Prematurity https:\/\/www.moh.gov.my\/moh\/attachments\/3917.pdf (2005, accessed 17 March 2021)."},{"key":"bibr37-11206721221126286","first-page":"58","volume":"45","author":"Philippine Pediatric Society, Philippine society of newborn medicine and philippine academy of ophthalmology \u2013 retinopathy of prematurity working group","year":"2020","journal-title":"Philipp J Ophthalmol"},{"key":"bibr38-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.219"},{"key":"bibr39-11206721221126286","unstructured":"The International Agency for the Prevention of Blindness - Latin America. Guidelines for ROP Screening and Treatment in Latin American Countries, https:\/\/web.archive.org\/web\/20210128112452\/http:\/\/www.sp-rop.com\/publicacoes\/2010_ROPGuidelines%20Latin%20American.pdf (2010, accessed 12 April 2021)."},{"key":"bibr40-11206721221126286","doi-asserted-by":"publisher","DOI":"10.5114\/ko.2020.94207"},{"key":"bibr41-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftal.2012.07.030"},{"key":"bibr42-11206721221126286","first-page":"253","volume":"74","author":"Zobanov\u00e1 A","year":"2018","journal-title":"Cesk Slov Oftalmol"},{"key":"bibr43-11206721221126286","unstructured":"Ministry of Health Kenya. National Guidelines for Screening and Management of Retinopathy of Prematurity in Kenya, https:\/\/www.health.go.ke\/wp-content\/uploads\/2021\/02\/National-Guidelines-for-Screening-and-Management-of-Retinopathy-of-Prematurity.2018.pdf (2018, accessed 4 March 2021)."},{"key":"bibr44-11206721221126286","unstructured":"United States Agency for International Development and Egyptian Ministry of Health. Complications of oxygen therapy. Neonatal care protocol for hospital physicians. Washington, DC: United States Agency for International Development, 2010, pp. 307\u2013308."},{"key":"bibr45-11206721221126286","unstructured":"Newborn Clinical Network and Paediatric Ophthalmology Interest Group. Consensus statement for screening for Retinopathy of Prematurity, https:\/\/media.starship.org.nz\/consensus-statement-for-screening-for-retinopathy-of-prematurity\/Retinopathy_of_Prematurity.pdf (2015, accessed 24 October 2021)."},{"key":"bibr46-11206721221126286","first-page":"59","volume":"70","author":"Prepiakova Z","year":"2014","journal-title":"Cesk Slov Oftalmol"},{"key":"bibr47-11206721221126286","unstructured":"Ministry of Health Malaysia. Panduan Amalan Klinikal (CPG), CPG - Eye Condition, https:\/\/www.moh.gov.my\/index.php\/pages\/view\/161?mid=75 (2020, accessed 17 March 2021)."},{"key":"bibr48-11206721221126286","unstructured":"Royal College of Paediatrics and Child Health. Screening and Treatment of Retinopathy of Prematurity - clinical guideline, https:\/\/www.rcpch.ac.uk\/resources\/screening-treatment-retinopathy-prematurity-clinical-guideline (2020, accessed 4 March 2021)."},{"key":"bibr49-11206721221126286","unstructured":"The World Bank Group. The World by Income and Region, https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html (2021, accessed 24 November 2021)."},{"key":"bibr50-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.05.031"},{"key":"bibr51-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31344-3"},{"key":"bibr52-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2018.04.002"},{"key":"bibr53-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.11.1470"},{"key":"bibr54-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01169-7"},{"key":"bibr55-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007374"},{"key":"bibr56-11206721221126286","unstructured":"European Medicines Agency. Lucentis: EPAR - Product Information, https:\/\/www.ema.europa.eu\/documents\/product-information\/lucentis-epar-product-information_en.pdf (2021, accessed 18 February 2022)."},{"key":"bibr57-11206721221126286","unstructured":"Royal College of Paediatrics and Child Health. Setting standards for the development of clinical guidelines in paediatrics and child health, https:\/\/www.rcpch.ac.uk\/sites\/default\/files\/2022-05\/Standards%20for%20development%20of%20paediatric%20guidelines%202020.pdf (2020, accessed 14 February 2022)."},{"key":"bibr58-11206721221126286","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318296e26d"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721221126286","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721221126286","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721221126286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:44:18Z","timestamp":1777405458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721221126286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1177\/11206721221126286"],"URL":"https:\/\/doi.org\/10.1177\/11206721221126286","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,18]]}}}